-
Tue24Sep2019Fri27Sep2019
-
Wed02Oct2019Fri04Oct2019
-
Thu10Oct2019Fri11Oct2019
-
Wed30Oct2019Fri01Nov2019
-
Thu31Oct2019Sat02Nov2019
-
Thu31Oct2019Sun03Nov2019
-
Mon04Nov2019Thu07Nov2019
-
Thu05Dec2019
Latest News
EVAR patients may experience significant long term decrease in renal function
A recent analysis, with some of the longest follow up to date, suggests that patients undergoing endovascular aneurysm repair (EVAR) may experience a significant...
Features
Training for rupture EVAR response: Formula 1 style
What do Formula 1 cars, space shuttles and airplanes have in common with a ruptured aneurysm? In this article, Colin Bicknell writes about the...
“More creative solutions” needed for end-stage vascular access patients
Nicholas (Nick) Inston calls for “more creative solutions” to vascular access challenges, commending interventional radiologists’ innovative reputation as instrumental to increasing the number of...
Videos
Ulf Teichgräber (Jena, Germany) and Koen Deloose (Dendermonde, Belgium) discuss the 24-month results of the EFFPAC trial and the six-month outcomes of the TINTIN trial. Both trials used the luminor drug-coated balloon (DCB; iVascular) with TINTIN testing it in...
(Visited 84,074 times, 7 visits today)
